10.46243/jst.2023.v8.i08.pp1-17 registered
Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease
Resolves to https://www.jst.org.in/index.php/pub/article/view/774
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2023.v8.i08.pp1-17
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 53bbd5684b31427f…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease (PrincipalTitle · en)
Published 2023-08-21
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 08 · issue 08 · pages 01–17
Agents
- Priyadarshini Roy (author)
- Lakshmi Nair (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2023.v8.i08.pp1-17
Abstract · en
Introduction: Lipotoxicity is a result of hyperlipidemia. Lipid and cholesterol buildup in the arteries causes atherosclerosis, which damages key organs including the heart and kidneys and causes cardiovascular disorders.Methods: Fasting blood samples were collected and tested using an automated biochemistry analyzer for dyslipidemia screening. Five participant groups—those with hypertension, diabetes, kidney disease, or liver disease—as well as a control group of people without these conditions—were used to collect the data. There were 101 patients in the study, with at least 20 volunteers in each group ranging in age from 18 to 70. The data were statistically compared using the independent two-sample t-test.Results: Hypertension and diabetes associated participants had an increased mean of low-density lipoprotein, very low-density lipoprotein, total cholesterol, and triglycerides levels than control (p<0.05). These were likewise higher in kidney disease patients compared to the control group (p<0.05). High-density lipoprotein levels did not change significantly in these groups. In liver disease patients mean triglycerides and very low-density lipoprotein levels were found significantly higher when compared to the control group (p<0.05). Mean high density lipoprotein levels in individuals with liver disease reveal a significant drop when compared to the control group, with a 90% confidence level.Conclusion: A link between hyperlipidemia and patients with hypertension, diabetes, liver disease, and renal disease was observed. Diabetes and high blood pressure were present in the majority of patients with renal and hepatic dysfunction.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2023.v8.i08.pp1-17 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Estimation of blood lipid profile to study dyslipidemia in patients with hypertension, diabetes, liver and kidney disease (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Priyadarshini Roy author: Lakshmi Nair publisher: Longman Publishers published: 2023-08-21 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 08 · no. 08 · pp. 01–17 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-08-27 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 44 references; 40 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Bobulescu IA. Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens. 2010 Jul;19(4):393-402. doi: 10.1097/ MNH.0b013e32833aa4ac, PMID 20489613 | 10.1097/mnh.0b013e32833aa4ac | not held here |
| 2 | ref2 Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011 Dec;13(6):544-52. doi: 10.1007/s11886-011- 0220-3, PMID 21968696 | 10.1007/s11886-011-0220-3 | not held here |
| 3 | ref3 Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1… | 10.1186/s12933-018-0762-4 | not held here |
| 4 | ref4 Jiang ZG, Robson SC, Yao Z. Lipoprotein metabolism in non-alcoholic fatty liver disease. J Biomed Res. 2013 Jan;27(1):1-13. doi: 10.7555/ JBR.27.20120077, PMID 23554788 | 10.7555/jbr.27.20120077 | not held here |
| 5 | ref5 Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight lo… | 10.1186/s12902-022-00980-1 | not held here |
| 6 | ref6 Przybyszewski EM, Targher G, Roden M, Corey KE. Nonalcoholic fatty liver disease and cardiovascular disease. Clin Liver Dis. 2021;17(1):19-22. doi: 10.1002/cld.1017, PMID 33552481 | 10.1002/cld.1017 | not held here |
| 7 | ref7 Choudhury D, Tuncel M, Levi M. Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol. 2009 Nov;29(6):610- | 10.1016/j.semnephrol.2009.07.006 | not held here |
| 8 | ref8 doi: 10.1016/j.semnephrol.2009.07.006, PMID 20006793 | 10.1016/j.semnephrol.2009.07.006 | not held here |
| 9 | ref9 Tao M, Wang HP, Sun J, Tian J. Progress of research on dyslipidemia accompanied by nephrotic syndrome. Chronic Dis Transl Med. 2020 Sep;6(3):182-7. doi: 10.1016/j. cdtm.2020.03.00… | 10.1016/j.cdtm.2020.03.002 | not held here |
| 10 | ref10 Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. La… | 10.1016/s0140-6736(13)60595-4 | not held here |
| 11 | ref11 Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol. 2012;56(6):1299-304. d… | 10.1016/j.jhep.2011.12.030 | not held here |
| 12 | ref12 Chen S, Cheng W. Relationship between lipid profiles and hypertension: A cross-sectional study of 62,957 Chinese adult males. Front Public Health. 2022; 10:895499. doi: 10.3389/ f… | 10.3389/fpubh.2022.895499 | not held here |
| 13 | ref13 Bønaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromsø study. Circulation. 1991;83(4, Apr):1305-14. doi: 10.1161/01.CIR.83.4.1305, PM… | 10.1161/01.cir.83.4.1305 | not held here |
| 14 | ref14 Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016 Mar… | 10.1161/jaha.115.003053 | not held here |
| 16 | ref16 Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep. 2013 Feb;15(1):59- | 10.1007/s11906-012-0323-2 | not held here |
| 17 | ref17 doi: 10.1007/s11906-012-0323-2, PMID 23242734 | 10.1007/s11906-012-0323-2 | not held here |
| 18 | ref18 Mänttäri M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension. 1995;26(4):670-5. doi: 10.1161/01.hyp.26.4.67… | 10.1161/01.hyp.26.4.670 | not held here |
| 19 | ref19 Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):2… | 10.1046/j.1523-1755.2000.00165.x | not held here |
| 20 | ref20 doi: 10.1046/j.1523-1755.2000.00165.x, PMID 10886574 | 10.1046/j.1523-1755.2000.00165.x | not held here |
| 21 | ref21 Visconti L, Benvenga S, Lacquaniti A, Cernaro V, Bruzzese A, Conti G et al. Lipid disorders in patients with renal failure: role in cardiovascular events and progression of chroni… | 10.1016/j.jcte.2016.08.002 | not held here |
| 22 | ref22 Zhang H, Shi S, Zhao XJ, Wang JK, Liu ZW, Liu FQ et al. Association between the lipid profile and renal dysfunction in the heart failure patients. Kidney Blood Press Res. 2019;44(… | 10.1159/000498834 | not held here |
| 23 | ref23 Lapinleimu H, Viikari J, Jokinen E, Routi T, Salo P, Hollo O et al. Cholesterol measurement by reflotron dry chemistry in infants, children and adults. Scand J Clin Lab Invest. 19… | 10.3109/00365519409086511 | not held here |
| 24 | ref24 doi: 10.3109/00365519409086511, PMID 8171273 | 10.3109/00365519409086511 | not held here |
| 25 | ref25 Moestrup SK, Nielsen LB. Nielsen et al. The role of the kidney in lipid metabolism. Curr Opin Lipidol. Jun 2005;16(3):301-6. doi: 10.1097/01. mol.0000169350.45944.d4, PMID 15891391 | 10.1097/01.mol.0000169350.45944.d4 | not held here |
| 27 | ref27 Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595-601. doi: 10.1161/01.HYP.0000145180.38707.84, PMID 1545… | 10.1161/01.hyp.0000145180.38707.84 | not held here |
| 28 | ref28 Wang T, Visentin M, Gerd A, Xianjun F, Wang Z, Zhibo G et al. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11(4),722:11040722. doi: 10.3390/nu | 10.3390/nu11040722 | not held here |
| 29 | ref29 Bhowmik B, Siddiquee T, Omsland KT. Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population (Int J Environ Res Public Health.2018. … | 10.3390/ijerph15091944 | not held here |
| 30 | ref30 Sadeghi E, Hosseini SM, Vossoughi M, Aminorroaya A, Amini M. Association of lipid profile with Type 2 diabetes in first-degree relatives: A 14-year follow-up study in Iran. Diabet… | 10.2147/dmso.s259697 | not held here |
| 31 | ref31 Indu KC, Deo RK, Roka K, Singh P, Alam Z. Study of Lipid profile in patients with Diabetes Mellitus presenting at tertiary referral center in Nepal, MJSBH vol. Vol. 21(1, Jan-Jun)… | 10.3126/mjsbh.v21i1.41605 | not held here |
| 32 | ref32 Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol. 2011 Nov;5(6):1572- | 10.1177/193229681100500634 | not held here |
| 33 | ref33 doi: 10.1177/193229681100500634, PMID 22226280 | 10.1177/193229681100500634 | not held here |
| 35 | ref35 Mengyang H, Ling Y, Lu Z, Liu Y, Gu P, Shao J et al. Contribution and interaction of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and trig… | 10.1111/jdi.12856 | not held here |
| 36 | ref36 Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab. 2013 Aug;24(8). Published online May 27:391-7:391-7. doi: 10.1016/j. tem.20… | 10.1016/j.tem.2013.04.001 | not held here |
| 38 | ref38 Mahaling DU, Basavaraj MM, Bika AJ. Comparison of lipid profile in different grades of nonalcoholic fatty liver disease diagnosed on ultrasound. Asian Pac J Trop Biomed. 2013;3(11… | 10.1016/s2221-1691(13)60177-x | not held here |
| 39 | ref39 Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F. Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the Persian Guilan cohort study … | 10.4103/jfmpc.jfmpc_243_18 | not held here |
| 40 | ref40 Kumari R, Kumar PS, Jana D. Dyslipidaemia in non-alcoholic fatty liver disease. IJSR. 2021:24- | 10.36106/ijsr/9739450 | not held here |
| 41 | ref41 doi: 10.36106/ijsr/9739450 | 10.36106/ijsr/9739450 | not held here |
| 42 | ref42 Cuenza LR, Razon TLJ, Dayrit JC. Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients. J Car… | 10.15171/jcvtr.2017.14 | not held here |
| 43 | ref43 Novakovic T, Mekic M, Smilic L, Smilic T, Inić-Kostic B, Jovicevic L et al. Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by n… | 10.5455/medarh.2014.68.22-26 | not held here |
| 44 | ref44 doi: 10.5455/medarh.2014.68.22-26, PMID 24783906 | 10.5455/medarh.2014.68.22-26 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 186 fields set · sha256 882399b79057… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 11 Sep 2026, 05:24 | Address updated from https://jst.org.in/index.php/pub/article/view/774/701 to https://www.jst.org.in/index.php/pub/article/view/774 | ● accepted by Crossref | 07b7172e3729… |
| 13 Sep 2026, 01:41 | Read back: the DOI resolves to the new address | ● confirmed | 62ff517d48b2… |
| 15 Oct 2026, 15:30 | Metadata completed abstract (126 words) · licence | ● accepted by Crossref | d52e237a28dd… |
| 15 Oct 2026, 16:20 | Read back: Crossref's record shows it | ● confirmed | e2368dce1c75… |
4 entries · the last fingerprint e2368dce1c755a4b9cce37cda0387be1021bff1c4481dd81176faa2533c42faf · the history as JSON, each entry with the fingerprint before it, to check them yourself.



